Navigation Links
Tissue Engineering Shows Promise to Revolutionize Transplant Medicine
Date:4/13/2011

SAN DIEGO, April 13, 2011 /PRNewswire/ -- The engineering of replacement tissue shows promise to dramatically impact the treatment of patients with end stage heart failure.  While the field is still in early stages, researchers will discuss the potential for a revolutionary change in medicine at the International Society for Heart & Lung Transplantation Annual Meeting and Scientific Sessions this week.

"We have opened the door to generating new complex organs," said Doris A. Taylor, PhD, University of Minnesota.

Dr. Taylor will moderate Thursday's Mid-Day Symposium 3: Immunological Aspects of Engineered Heart Tissue and Cellular Replacement Therapies in Heart Failure.

According to Dr. Taylor, creating bioartificial organs requires cells, a framework for the cells and a way to feed these cells. Building any complex organ, a heart or lung for instance, requires a complex interplay between cells, their microenvironments and the vascular network, which ultimately impacts cell differentiation.

Beyond transplantation, tissue engineering holds potential for building pieces of organs and tissues for use in repair of these organs.

On Friday, Dr. Taylor will discuss her own research during the Mid-Day Symposium 5:  Future Therapies for End-Stage Thoracic Organ Failure. Dr. Taylor's discussion: Is There a Future for Engineered Heart and Lung, will explore how matrix provides an architecturally correct 3-D microenvironment for developing cells and the biologic structural cues that drive cell behavior. She will discuss the impact of matrix on stem or progenitor cell alignment, differentiation, function and physiology, as well as its use as an in vitro test bed to evaluate stem cell repair.

"Engineering solutions to disease is no longer science fiction. Tissue engineering has the potential to revolutionize how humans think of health and disease," said Dr. Taylor.

Dr. Taylor noted that tracheas and bladders from decellularized matrix are already in clinical study. As the field advances, progressively more complex organs will be transplanted.

"Our hope is that this technology will make end stage heart and lung disease a problem of the past.  We are working towards generating autologous organs and reducing the burden of organ rejection," Dr. Taylor continued.

About ISHLT

The International Society for Heart & Lung Transplantation (ISHLT) is a not-for-profit organization dedicated to the advancement of the science and treatment of end-stage heart and lung diseases.  Established in 1981, the Society now includes more than 2,200 members from 45-plus countries, representing a variety of disciplines involved in the management and treatment of end-stage heart and lung disease.

ISHLT maintains two vital databases.  The International Heart &  Lung Transplant Registry is a one-of-a-kind registry that has been collecting data since 1983 from 223 hospitals from 18 countries.  The ISHLT Mechanical Circulatory Support Device (MCSD) database has been collecting data since 2002 with the aim of identifying patient populations who may benefit from MCSD implantation; generating predictive models for outcomes; and assessing the mechanical and biological reliability of current and future devices.  In Fall 2006, ISHLT released the first international guidelines for heart failure patient management.  For more information, visit www.ishlt.org.

Contact:  Megan Augustine
(210) 296-9520
megana@proterraadvertising.com


'/>"/>
SOURCE International Society for Heart & Lung Transplantation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Cellular Dynamics Raises $30 Million to Expand Its Product Line of Human Stem Cells and Tissue Cells
2. Pathfinder Cells Demonstrate Ability to Regenerate Damaged Tissue and Restore Pancreatic Function in a Diabetic Mouse Model
3. Global Cell/Tissue Culture Supplies Industry
4. Healthier Healing for Hip Resurfacing - ICAP Ocean Tomo Announces Auction of an Advanced Hip Cap for Electromagnetic Tissue Stimulation by Neue Magnetodyn.
5. Caliper Life Sciences and HistoRx to Provide Integrated Solutions for Superior Protein Quantification of Biomarkers in Tissue
6. Celleration Inc. Announces Award-Winning Clinical Results to Reduce Unfavorable Deep Tissue Injury Outcomes
7. Leaders of Health in High-Def Grow Tissue to Get Patients Back on Their Feet
8. BioStorage Technologies Partners with AMDeC, LLC to Provide Tissue Storage and Cold Chain Logistics Services to Academic Medical Research Institutions
9. Stryker Features Tissue-Preservation Hip Arthroscopy Platform, Sponsors Surgeon Education Events at the AAOS Annual Meeting
10. Biomerix Granted CE Mark for its REVIVE™ Soft Tissue Repair Mesh
11. Reportlinker Adds European Markets for Dental Bone Graft Substitutes, Dental Membranes and Tissue Engineering 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... Following receiving CE Marking in ... s AMAR is a major milestone for the country where the device ... care market in Israel   ... for inclusion in the National Health Basket , Israel ... E-QURE Corp. (OTCQB: EQUR), a leader in medical devices for the treatment of ...
(Date:2/24/2017)... Research and Markets has announced the addition of the "Global ... report to their offering. ... The Global Empty Capsules Market is poised to grow at a CAGR ... by 2025. This industry report analyzes the market estimates ... regional levels presented in the research scope. The study provides historical market ...
(Date:2/24/2017)... Pa. , Feb. 24, 2017 Physician ... of Drug and Alcohol Programs Jennifer Smith ... in providing training for and using naloxone, a life-saving ... Mark McCullough , a recovery specialist and overdose survivor ... by EMS providers. "A significant part of ...
Breaking Medicine Technology:
(Date:2/24/2017)... (PRWEB) , ... February 24, 2017 , ... ... qualifying into the Senior International Elite division on February 12th. Ms. Esparza ... divisions at the elite qualifier competition held in Las Vegas, Nevada. Frida is ...
(Date:2/23/2017)... ... 2017 , ... Thinksport, the most award-winning sunscreen on the ... Marin. For the second year in a row, cyclists will stay protected from ... thrilled to provide our safe, non-toxic sunscreen to over 2,000 cycling enthusiasts again ...
(Date:2/23/2017)... ... ... The 89th Academy Awards will be celebrated this weekend, which means it’s ... Award. We invite you to enjoy our 11th annual tongue-in-cheek “salute” to the shoddiest ... for American Progress (CAP), for its report, Lessons From State Performance on NAEP: Why ...
(Date:2/23/2017)... NJ (PRWEB) , ... February 23, 2017 , ... ... media outlet with a clinician-based audience, will be participating in Rare Disease Day ... in Washington, D.C. In addition, Rare Disease Report, a website, weekly e-newsletter and ...
(Date:2/23/2017)... ... February 23, 2017 , ... Los Angeles-based weight loss surgeon Michael ... “Mama June: From Not to Hot,” which will begin airing on February 24, 2017. ... to millions from the 2012 reality television series, “Here Comes Honey Boo Boo.” The ...
Breaking Medicine News(10 mins):